

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | snRNA processing (GO:0016180) | 7.09102045 |
| 2 | protein K11-linked deubiquitination (GO:0035871) | 6.99763416 |
| 3 | snRNA metabolic process (GO:0016073) | 6.36558423 |
| 4 | rRNA catabolic process (GO:0016075) | 6.24248893 |
| 5 | peptidyl-threonine dephosphorylation (GO:0035970) | 6.17136090 |
| 6 | mitochondrion degradation (GO:0000422) | 6.07323310 |
| 7 | regulation of MHC class II biosynthetic process (GO:0045346) | 5.59036278 |
| 8 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 5.48962156 |
| 9 | rRNA modification (GO:0000154) | 5.45487729 |
| 10 | mismatch repair (GO:0006298) | 5.40364215 |
| 11 | histone H3-K4 trimethylation (GO:0080182) | 5.39634066 |
| 12 | rRNA methylation (GO:0031167) | 5.32493587 |
| 13 | purine nucleobase biosynthetic process (GO:0009113) | 4.87015508 |
| 14 | C-terminal protein lipidation (GO:0006501) | 4.83155347 |
| 15 | reciprocal DNA recombination (GO:0035825) | 4.76038722 |
| 16 | reciprocal meiotic recombination (GO:0007131) | 4.76038722 |
| 17 | acrosome assembly (GO:0001675) | 4.71302306 |
| 18 | kynurenine metabolic process (GO:0070189) | 4.53174417 |
| 19 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 4.53009893 |
| 20 | cellular response to exogenous dsRNA (GO:0071360) | 4.35119334 |
| 21 | positive regulation of defense response to virus by host (GO:0002230) | 4.30329922 |
| 22 | C-terminal protein amino acid modification (GO:0018410) | 4.27712855 |
| 23 | nucleobase biosynthetic process (GO:0046112) | 4.26225098 |
| 24 | IMP biosynthetic process (GO:0006188) | 4.24123324 |
| 25 | indole-containing compound catabolic process (GO:0042436) | 4.23312583 |
| 26 | indolalkylamine catabolic process (GO:0046218) | 4.23312583 |
| 27 | tryptophan catabolic process (GO:0006569) | 4.23312583 |
| 28 | fucose catabolic process (GO:0019317) | 4.17455943 |
| 29 | L-fucose metabolic process (GO:0042354) | 4.17455943 |
| 30 | L-fucose catabolic process (GO:0042355) | 4.17455943 |
| 31 | auditory receptor cell stereocilium organization (GO:0060088) | 4.07799302 |
| 32 | positive regulation of histone H3-K4 methylation (GO:0051571) | 4.07170947 |
| 33 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 4.04938645 |
| 34 | DNA deamination (GO:0045006) | 4.02890416 |
| 35 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 3.98612287 |
| 36 | N-acetylneuraminate metabolic process (GO:0006054) | 3.96046960 |
| 37 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.94497891 |
| 38 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.91033491 |
| 39 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 3.85436281 |
| 40 | negative regulation of NF-kappaB import into nucleus (GO:0042347) | 3.80998990 |
| 41 | negative regulation of type I interferon production (GO:0032480) | 3.79321093 |
| 42 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.78733040 |
| 43 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.76278511 |
| 44 | positive regulation of mitochondrial fission (GO:0090141) | 3.75482510 |
| 45 | inner ear receptor stereocilium organization (GO:0060122) | 3.71632249 |
| 46 | positive regulation of cytokinesis (GO:0032467) | 3.71109285 |
| 47 | regulation of meiosis I (GO:0060631) | 3.68498756 |
| 48 | vesicle targeting (GO:0006903) | 3.67764463 |
| 49 | tryptophan metabolic process (GO:0006568) | 3.63365434 |
| 50 | female gamete generation (GO:0007292) | 3.62788659 |
| 51 | granulocyte differentiation (GO:0030851) | 3.60099494 |
| 52 | ncRNA catabolic process (GO:0034661) | 3.59781299 |
| 53 | carnitine metabolic process (GO:0009437) | 3.57897865 |
| 54 | IMP metabolic process (GO:0046040) | 3.56776625 |
| 55 | mitochondrial RNA metabolic process (GO:0000959) | 3.38790202 |
| 56 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 3.33810272 |
| 57 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.28361527 |
| 58 | base-excision repair, AP site formation (GO:0006285) | 3.14956293 |
| 59 | indolalkylamine metabolic process (GO:0006586) | 3.14551417 |
| 60 | regulation of triglyceride biosynthetic process (GO:0010866) | 3.12565349 |
| 61 | negative regulation of meiosis (GO:0045835) | 3.11147812 |
| 62 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 3.08511613 |
| 63 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.07364502 |
| 64 | ATP synthesis coupled proton transport (GO:0015986) | 3.07364502 |
| 65 | interleukin-6-mediated signaling pathway (GO:0070102) | 3.07310496 |
| 66 | negative regulation of defense response to virus (GO:0050687) | 3.00485753 |
| 67 | meiosis I (GO:0007127) | 2.99737554 |
| 68 | regulation of defense response to virus by host (GO:0050691) | 2.98862884 |
| 69 | behavioral response to nicotine (GO:0035095) | 2.97963663 |
| 70 | somite development (GO:0061053) | 2.93256507 |
| 71 | regulation of mitochondrial fission (GO:0090140) | 2.92803249 |
| 72 | response to pheromone (GO:0019236) | 2.91392668 |
| 73 | peptidyl-lysine trimethylation (GO:0018023) | 2.90402976 |
| 74 | amino-acid betaine metabolic process (GO:0006577) | 2.90043191 |
| 75 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.89429547 |
| 76 | positive regulation of DNA-templated transcription, elongation (GO:0032786) | 2.88833518 |
| 77 | cellular response to dsRNA (GO:0071359) | 2.88827820 |
| 78 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 2.87979852 |
| 79 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 2.87979852 |
| 80 | interkinetic nuclear migration (GO:0022027) | 2.87261357 |
| 81 | regulation of memory T cell differentiation (GO:0043380) | 2.86300943 |
| 82 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.83767502 |
| 83 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.83767502 |
| 84 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.83767502 |
| 85 | DNA replication checkpoint (GO:0000076) | 2.82610923 |
| 86 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.81865238 |
| 87 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.81091550 |
| 88 | male meiosis (GO:0007140) | 2.80496701 |
| 89 | regulation of histone H3-K4 methylation (GO:0051569) | 2.80476798 |
| 90 | axonemal dynein complex assembly (GO:0070286) | 2.79976642 |
| 91 | adenosine metabolic process (GO:0046085) | 2.78760159 |
| 92 | protein-cofactor linkage (GO:0018065) | 2.75636785 |
| 93 | chaperone-mediated protein transport (GO:0072321) | 2.71513482 |
| 94 | N-acetylglucosamine metabolic process (GO:0006044) | 2.70624105 |
| 95 | positive regulation of digestive system process (GO:0060456) | 2.69235059 |
| 96 | cell fate commitment involved in formation of primary germ layer (GO:0060795) | 2.69059401 |
| 97 | positive regulation of granulocyte differentiation (GO:0030854) | 2.66518897 |
| 98 | pseudouridine synthesis (GO:0001522) | 2.66236891 |
| 99 | protein K63-linked deubiquitination (GO:0070536) | 2.64840647 |
| 100 | meiotic chromosome segregation (GO:0045132) | 10.0908445 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 4.70207797 |
| 2 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 4.29758390 |
| 3 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.90850343 |
| 4 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.01777910 |
| 5 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.97855863 |
| 6 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.97350734 |
| 7 | EWS_26573619_Chip-Seq_HEK293_Human | 2.80990453 |
| 8 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.69113519 |
| 9 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.46761489 |
| 10 | VDR_22108803_ChIP-Seq_LS180_Human | 2.45147401 |
| 11 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.38517022 |
| 12 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.35713398 |
| 13 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.27480641 |
| 14 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.14742971 |
| 15 | MYC_18940864_ChIP-ChIP_HL60_Human | 2.08942953 |
| 16 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.07425496 |
| 17 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.99798794 |
| 18 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.91002050 |
| 19 | FUS_26573619_Chip-Seq_HEK293_Human | 1.90281352 |
| 20 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.89298926 |
| 21 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.83772224 |
| 22 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.70192705 |
| 23 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.68475142 |
| 24 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.67629234 |
| 25 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.66082928 |
| 26 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.66082928 |
| 27 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.63491206 |
| 28 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.59741567 |
| 29 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.58235237 |
| 30 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.57002323 |
| 31 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.54233528 |
| 32 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.52899504 |
| 33 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.52258798 |
| 34 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.50437996 |
| 35 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.50367268 |
| 36 | AR_20517297_ChIP-Seq_VCAP_Human | 1.48332226 |
| 37 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.47904694 |
| 38 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.45421149 |
| 39 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.45014845 |
| 40 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.45014845 |
| 41 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.44807981 |
| 42 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.44413645 |
| 43 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.44382101 |
| 44 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.42236749 |
| 45 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.40316260 |
| 46 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.40316260 |
| 47 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 1.40059022 |
| 48 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.38929634 |
| 49 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.38796145 |
| 50 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.38692357 |
| 51 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.38638035 |
| 52 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.37284205 |
| 53 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.36817139 |
| 54 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.36382359 |
| 55 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.35302492 |
| 56 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.34153092 |
| 57 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.33026882 |
| 58 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.32961633 |
| 59 | P300_19829295_ChIP-Seq_ESCs_Human | 1.31892520 |
| 60 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.31487713 |
| 61 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.30198668 |
| 62 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.30058513 |
| 63 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.27629467 |
| 64 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.23569970 |
| 65 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.21255336 |
| 66 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.20669990 |
| 67 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.19247068 |
| 68 | TCF4_23295773_ChIP-Seq_U87_Human | 1.17823279 |
| 69 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.17158785 |
| 70 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 1.16634473 |
| 71 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.15182439 |
| 72 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.14695545 |
| 73 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.12782090 |
| 74 | RBPJ_21746931_ChIP-Seq_IB4_Human | 1.11593690 |
| 75 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.10201169 |
| 76 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.08973843 |
| 77 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.06743463 |
| 78 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.05454516 |
| 79 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.03821929 |
| 80 | NCOR_22424771_ChIP-Seq_293T_Human | 1.03009833 |
| 81 | ETV1_20927104_ChIP-Seq_GIST48_Human | 1.00786111 |
| 82 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00690801 |
| 83 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.99257441 |
| 84 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99034524 |
| 85 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.98871487 |
| 86 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.98263342 |
| 87 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.97816809 |
| 88 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.97604957 |
| 89 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.96933518 |
| 90 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.95234946 |
| 91 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.94687412 |
| 92 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.94687412 |
| 93 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.93641092 |
| 94 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.93629835 |
| 95 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.92437362 |
| 96 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.92330343 |
| 97 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.92324227 |
| 98 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.91341235 |
| 99 | GATA3_26560356_Chip-Seq_TH2_Human | 0.90239428 |
| 100 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.88768174 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005646_abnormal_pituitary_gland | 3.70134338 |
| 2 | MP0005310_abnormal_salivary_gland | 3.63288145 |
| 3 | MP0006072_abnormal_retinal_apoptosis | 3.49872154 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 3.45492685 |
| 5 | MP0003011_delayed_dark_adaptation | 3.36708055 |
| 6 | MP0004484_altered_response_of | 2.93959146 |
| 7 | MP0009764_decreased_sensitivity_to | 2.74220426 |
| 8 | MP0003136_yellow_coat_color | 2.67349699 |
| 9 | MP0004147_increased_porphyrin_level | 2.67205372 |
| 10 | MP0003718_maternal_effect | 2.35187007 |
| 11 | MP0005551_abnormal_eye_electrophysiolog | 2.33826266 |
| 12 | MP0003195_calcinosis | 2.23367321 |
| 13 | MP0005253_abnormal_eye_physiology | 2.18225847 |
| 14 | MP0002876_abnormal_thyroid_physiology | 2.15723998 |
| 15 | MP0008877_abnormal_DNA_methylation | 2.09130364 |
| 16 | MP0008872_abnormal_physiological_respon | 2.02919340 |
| 17 | MP0009379_abnormal_foot_pigmentation | 1.92181099 |
| 18 | MP0009780_abnormal_chondrocyte_physiolo | 1.91730240 |
| 19 | MP0008058_abnormal_DNA_repair | 1.91280650 |
| 20 | MP0005167_abnormal_blood-brain_barrier | 1.89245230 |
| 21 | MP0005365_abnormal_bile_salt | 1.89076729 |
| 22 | MP0001764_abnormal_homeostasis | 1.88561051 |
| 23 | MP0008875_abnormal_xenobiotic_pharmacok | 1.87499226 |
| 24 | MP0003646_muscle_fatigue | 1.86964519 |
| 25 | MP0004885_abnormal_endolymph | 1.81526728 |
| 26 | MP0000372_irregular_coat_pigmentation | 1.65033193 |
| 27 | MP0004742_abnormal_vestibular_system | 1.64909808 |
| 28 | MP0002928_abnormal_bile_duct | 1.61160129 |
| 29 | MP0005410_abnormal_fertilization | 1.59919781 |
| 30 | MP0002638_abnormal_pupillary_reflex | 1.53987295 |
| 31 | MP0009697_abnormal_copulation | 1.52631656 |
| 32 | MP0000631_abnormal_neuroendocrine_gland | 1.51603992 |
| 33 | MP0009643_abnormal_urine_homeostasis | 1.49885348 |
| 34 | MP0005360_urolithiasis | 1.48561931 |
| 35 | MP0004043_abnormal_pH_regulation | 1.47574774 |
| 36 | MP0009745_abnormal_behavioral_response | 1.47011019 |
| 37 | MP0002138_abnormal_hepatobiliary_system | 1.36790737 |
| 38 | MP0004215_abnormal_myocardial_fiber | 1.35347164 |
| 39 | MP0005332_abnormal_amino_acid | 1.31279962 |
| 40 | MP0003638_abnormal_response/metabolism_ | 1.29850926 |
| 41 | MP0002254_reproductive_system_inflammat | 1.27621774 |
| 42 | MP0002693_abnormal_pancreas_physiology | 1.27172280 |
| 43 | MP0004957_abnormal_blastocyst_morpholog | 1.21507858 |
| 44 | MP0010094_abnormal_chromosome_stability | 1.18044043 |
| 45 | MP0005084_abnormal_gallbladder_morpholo | 1.13945717 |
| 46 | MP0006292_abnormal_olfactory_placode | 1.13917131 |
| 47 | MP0003878_abnormal_ear_physiology | 1.12913440 |
| 48 | MP0005377_hearing/vestibular/ear_phenot | 1.12913440 |
| 49 | MP0004782_abnormal_surfactant_physiolog | 1.11939297 |
| 50 | MP0005165_increased_susceptibility_to | 1.09314609 |
| 51 | MP0002127_abnormal_cardiovascular_syste | 1.06351272 |
| 52 | MP0002210_abnormal_sex_determination | 1.05523629 |
| 53 | MP0005187_abnormal_penis_morphology | 1.04281111 |
| 54 | MP0001324_abnormal_eye_pigmentation | 1.02281853 |
| 55 | MP0001502_abnormal_circadian_rhythm | 1.01478803 |
| 56 | MP0001666_abnormal_nutrient_absorption | 1.01377527 |
| 57 | MP0005671_abnormal_response_to | 0.99966341 |
| 58 | MP0002938_white_spotting | 0.99245783 |
| 59 | MP0001905_abnormal_dopamine_level | 0.99094268 |
| 60 | MP0002102_abnormal_ear_morphology | 0.98806229 |
| 61 | MP0008775_abnormal_heart_ventricle | 0.98453579 |
| 62 | MP0004133_heterotaxia | 0.96895290 |
| 63 | MP0003787_abnormal_imprinting | 0.96376058 |
| 64 | MP0006036_abnormal_mitochondrial_physio | 0.95378984 |
| 65 | MP0000230_abnormal_systemic_arterial | 0.92570159 |
| 66 | MP0005195_abnormal_posterior_eye | 0.91503861 |
| 67 | MP0000383_abnormal_hair_follicle | 0.90182165 |
| 68 | MP0002090_abnormal_vision | 0.87267061 |
| 69 | MP0004084_abnormal_cardiac_muscle | 0.86680850 |
| 70 | MP0002277_abnormal_respiratory_mucosa | 0.85817928 |
| 71 | MP0001986_abnormal_taste_sensitivity | 0.85453631 |
| 72 | MP0001501_abnormal_sleep_pattern | 0.85243230 |
| 73 | MP0002733_abnormal_thermal_nociception | 0.84320948 |
| 74 | MP0005391_vision/eye_phenotype | 0.83144773 |
| 75 | MP0001929_abnormal_gametogenesis | 0.82205903 |
| 76 | MP0001293_anophthalmia | 0.82004729 |
| 77 | MP0001188_hyperpigmentation | 0.81897160 |
| 78 | MP0001970_abnormal_pain_threshold | 0.79979812 |
| 79 | MP0002136_abnormal_kidney_physiology | 0.79820051 |
| 80 | MP0001800_abnormal_humoral_immune | 0.79702011 |
| 81 | MP0003221_abnormal_cardiomyocyte_apopto | 0.79544588 |
| 82 | MP0006276_abnormal_autonomic_nervous | 0.78944632 |
| 83 | MP0003698_abnormal_male_reproductive | 0.78120337 |
| 84 | MP0010386_abnormal_urinary_bladder | 0.77463004 |
| 85 | MP0005645_abnormal_hypothalamus_physiol | 0.75646173 |
| 86 | MP0002723_abnormal_immune_serum | 0.74313539 |
| 87 | MP0005395_other_phenotype | 0.73612260 |
| 88 | MP0005075_abnormal_melanosome_morpholog | 0.72454332 |
| 89 | MP0000653_abnormal_sex_gland | 0.71691117 |
| 90 | MP0001119_abnormal_female_reproductive | 0.70931107 |
| 91 | MP0004085_abnormal_heartbeat | 0.70327185 |
| 92 | MP0001286_abnormal_eye_development | 0.69196270 |
| 93 | MP0002557_abnormal_social/conspecific_i | 0.68829559 |
| 94 | MP0008469_abnormal_protein_level | 0.68721576 |
| 95 | MP0000427_abnormal_hair_cycle | 0.68578858 |
| 96 | MP0005647_abnormal_sex_gland | 0.68065483 |
| 97 | MP0002272_abnormal_nervous_system | 0.68013029 |
| 98 | MP0002234_abnormal_pharynx_morphology | 0.65456588 |
| 99 | MP0001968_abnormal_touch/_nociception | 0.64598444 |
| 100 | MP0002095_abnormal_skin_pigmentation | 0.63797201 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 5.19058609 |
| 2 | Abnormal rod and cone electroretinograms (HP:0008323) | 4.56376894 |
| 3 | Abnormal biliary tract physiology (HP:0012439) | 4.39782642 |
| 4 | Bile duct proliferation (HP:0001408) | 4.39782642 |
| 5 | Pigmentary retinal degeneration (HP:0001146) | 4.28350315 |
| 6 | Chronic bronchitis (HP:0004469) | 4.20194018 |
| 7 | Pancreatic cysts (HP:0001737) | 4.07277818 |
| 8 | Choroideremia (HP:0001139) | 4.03924572 |
| 9 | Congenital stationary night blindness (HP:0007642) | 3.95741477 |
| 10 | True hermaphroditism (HP:0010459) | 3.73661128 |
| 11 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.71796693 |
| 12 | Decreased central vision (HP:0007663) | 3.57150542 |
| 13 | Pancreatic fibrosis (HP:0100732) | 3.49463419 |
| 14 | Lipid accumulation in hepatocytes (HP:0006561) | 3.38273264 |
| 15 | Decreased circulating renin level (HP:0003351) | 3.37607782 |
| 16 | Attenuation of retinal blood vessels (HP:0007843) | 3.35388446 |
| 17 | Molar tooth sign on MRI (HP:0002419) | 3.09563190 |
| 18 | Abnormality of midbrain morphology (HP:0002418) | 3.09563190 |
| 19 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.00003003 |
| 20 | Abnormality of alanine metabolism (HP:0010916) | 3.00003003 |
| 21 | Hyperalaninemia (HP:0003348) | 3.00003003 |
| 22 | Thyroid-stimulating hormone excess (HP:0002925) | 2.99981719 |
| 23 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.77745113 |
| 24 | Abnormality of the pons (HP:0007361) | 2.73041828 |
| 25 | Increased hepatocellular lipid droplets (HP:0006565) | 2.70270834 |
| 26 | Hypoplasia of the pons (HP:0012110) | 2.63887245 |
| 27 | Rimmed vacuoles (HP:0003805) | 2.57084875 |
| 28 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.51410850 |
| 29 | Flat occiput (HP:0005469) | 2.50537341 |
| 30 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.49055956 |
| 31 | Central scotoma (HP:0000603) | 2.49045359 |
| 32 | Chronic hepatic failure (HP:0100626) | 2.40640065 |
| 33 | Biliary tract neoplasm (HP:0100574) | 2.38332591 |
| 34 | Constricted visual fields (HP:0001133) | 2.35171871 |
| 35 | Severe Myopia (HP:0011003) | 2.33828426 |
| 36 | Ependymoma (HP:0002888) | 2.27549057 |
| 37 | Mitochondrial inheritance (HP:0001427) | 2.27235071 |
| 38 | Cystic liver disease (HP:0006706) | 2.26998881 |
| 39 | Abnormality of the renal cortex (HP:0011035) | 2.25179149 |
| 40 | Bronchitis (HP:0012387) | 2.22092210 |
| 41 | Abnormal number of erythroid precursors (HP:0012131) | 2.19084326 |
| 42 | Type II lissencephaly (HP:0007260) | 2.17690997 |
| 43 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.17283157 |
| 44 | Increased serum lactate (HP:0002151) | 2.17187835 |
| 45 | Meckel diverticulum (HP:0002245) | 2.16556624 |
| 46 | Neutropenia (HP:0001875) | 2.15532036 |
| 47 | Rhinitis (HP:0012384) | 2.14459966 |
| 48 | Hyperkalemia (HP:0002153) | 2.14445057 |
| 49 | Polydipsia (HP:0001959) | 2.12551967 |
| 50 | Abnormal drinking behavior (HP:0030082) | 2.12551967 |
| 51 | Conical tooth (HP:0000698) | 2.11265025 |
| 52 | 3-Methylglutaconic aciduria (HP:0003535) | 2.10805395 |
| 53 | Colon cancer (HP:0003003) | 2.10550904 |
| 54 | IgG deficiency (HP:0004315) | 2.10485581 |
| 55 | IgM deficiency (HP:0002850) | 2.07996429 |
| 56 | Increased CSF lactate (HP:0002490) | 2.07603607 |
| 57 | Hypokalemic alkalosis (HP:0001949) | 2.05193804 |
| 58 | Recurrent otitis media (HP:0000403) | 2.05098838 |
| 59 | Oral leukoplakia (HP:0002745) | 2.03189200 |
| 60 | Abnormality of the ileum (HP:0001549) | 2.03029824 |
| 61 | Furrowed tongue (HP:0000221) | 2.02720885 |
| 62 | Anencephaly (HP:0002323) | 2.02109441 |
| 63 | Congenital hepatic fibrosis (HP:0002612) | 1.98853756 |
| 64 | Nephronophthisis (HP:0000090) | 1.98602773 |
| 65 | Cerebellar dysplasia (HP:0007033) | 1.97929832 |
| 66 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.97695721 |
| 67 | Congenital, generalized hypertrichosis (HP:0004540) | 1.97228324 |
| 68 | Acute necrotizing encephalopathy (HP:0006965) | 1.96417936 |
| 69 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.95701732 |
| 70 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.95701732 |
| 71 | Confusion (HP:0001289) | 1.95051981 |
| 72 | Sclerocornea (HP:0000647) | 1.94932224 |
| 73 | Aplastic anemia (HP:0001915) | 1.91348861 |
| 74 | Respiratory difficulties (HP:0002880) | 1.90853072 |
| 75 | Hepatocellular necrosis (HP:0001404) | 1.90744270 |
| 76 | Supernumerary spleens (HP:0009799) | 1.89849137 |
| 77 | Male pseudohermaphroditism (HP:0000037) | 1.85296832 |
| 78 | Abnormality of the preputium (HP:0100587) | 1.84921272 |
| 79 | Hepatic necrosis (HP:0002605) | 1.84868867 |
| 80 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.83781419 |
| 81 | Renal Fanconi syndrome (HP:0001994) | 1.81541055 |
| 82 | Abnormality of renin-angiotensin system (HP:0000847) | 1.81204876 |
| 83 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.80723251 |
| 84 | Renal cortical cysts (HP:0000803) | 1.80436595 |
| 85 | Hyperactive renin-angiotensin system (HP:0000841) | 1.77924531 |
| 86 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.77574580 |
| 87 | Retinitis pigmentosa (HP:0000510) | 1.77446812 |
| 88 | Increased cerebral lipofuscin (HP:0011813) | 1.77121159 |
| 89 | Abolished electroretinogram (ERG) (HP:0000550) | 1.76825692 |
| 90 | Occipital encephalocele (HP:0002085) | 1.76053343 |
| 91 | Glioma (HP:0009733) | 1.74130855 |
| 92 | Polyuria (HP:0000103) | 1.73134896 |
| 93 | Clubbing of toes (HP:0100760) | 1.72900229 |
| 94 | Pendular nystagmus (HP:0012043) | 1.72263711 |
| 95 | Hypoalbuminemia (HP:0003073) | 1.71805606 |
| 96 | Abnormal albumin level (HP:0012116) | 1.71805606 |
| 97 | Lactic acidosis (HP:0003128) | 1.71713691 |
| 98 | Increased muscle lipid content (HP:0009058) | 1.71065940 |
| 99 | Opisthotonus (HP:0002179) | 1.71015594 |
| 100 | Hyperaldosteronism (HP:0000859) | 1.70934982 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BLK | 7.90254516 |
| 2 | MAP3K9 | 4.95924996 |
| 3 | ZAK | 3.43153733 |
| 4 | FRK | 3.35341995 |
| 5 | CAMKK2 | 3.27318493 |
| 6 | CAMK1D | 2.69451570 |
| 7 | PINK1 | 2.16754524 |
| 8 | VRK2 | 2.12603526 |
| 9 | NUAK1 | 2.02464854 |
| 10 | MAPKAPK5 | 1.92614773 |
| 11 | SRPK1 | 1.87591093 |
| 12 | GRK1 | 1.85686118 |
| 13 | DYRK3 | 1.78696016 |
| 14 | TLK1 | 1.74407913 |
| 15 | VRK1 | 1.65995586 |
| 16 | WNK3 | 1.62496191 |
| 17 | MST4 | 1.61843718 |
| 18 | CAMK1G | 1.58250051 |
| 19 | TAOK3 | 1.51013360 |
| 20 | MKNK1 | 1.49496275 |
| 21 | ADRBK2 | 1.45274430 |
| 22 | TAF1 | 1.41502739 |
| 23 | RPS6KA4 | 1.35390695 |
| 24 | PDK1 | 1.31931616 |
| 25 | TNK2 | 1.31666027 |
| 26 | DYRK2 | 1.24999627 |
| 27 | PDPK1 | 1.23045529 |
| 28 | WNK4 | 1.20996017 |
| 29 | TSSK6 | 1.17687939 |
| 30 | TXK | 1.14394938 |
| 31 | CDC7 | 1.12211168 |
| 32 | BUB1 | 1.10461358 |
| 33 | CAMK4 | 1.03974577 |
| 34 | MKNK2 | 1.00167717 |
| 35 | MAPKAPK3 | 0.98328851 |
| 36 | OXSR1 | 0.96029795 |
| 37 | PLK3 | 0.93551709 |
| 38 | NEK1 | 0.91514244 |
| 39 | MAP4K2 | 0.86038157 |
| 40 | STK38L | 0.85273529 |
| 41 | HIPK2 | 0.85113886 |
| 42 | EPHA4 | 0.84252378 |
| 43 | DAPK2 | 0.83197302 |
| 44 | MELK | 0.81043685 |
| 45 | ITK | 0.80261415 |
| 46 | CAMKK1 | 0.79415932 |
| 47 | MUSK | 0.77134302 |
| 48 | RPS6KA5 | 0.76176125 |
| 49 | STK16 | 0.74196094 |
| 50 | TESK2 | 0.73987029 |
| 51 | KIT | 0.73673350 |
| 52 | MARK3 | 0.72069361 |
| 53 | IKBKB | 0.69839053 |
| 54 | STK39 | 0.67668678 |
| 55 | ATR | 0.64405104 |
| 56 | FLT3 | 0.64327463 |
| 57 | PASK | 0.62204215 |
| 58 | BMPR1B | 0.60415084 |
| 59 | ALK | 0.59250981 |
| 60 | PLK4 | 0.56862827 |
| 61 | CSNK1E | 0.55568731 |
| 62 | PRKCQ | 0.53436541 |
| 63 | ACVR1B | 0.51260467 |
| 64 | WEE1 | 0.51151365 |
| 65 | PLK1 | 0.50781054 |
| 66 | ADRBK1 | 0.50627252 |
| 67 | PBK | 0.50602872 |
| 68 | AURKB | 0.49433858 |
| 69 | LYN | 0.46628920 |
| 70 | CDK19 | 0.46538156 |
| 71 | NLK | 0.45710793 |
| 72 | EIF2AK3 | 0.44884286 |
| 73 | PRKCE | 0.44734447 |
| 74 | CSNK2A2 | 0.44080378 |
| 75 | MAPK15 | 0.42981672 |
| 76 | CDK9 | 0.42448963 |
| 77 | INSRR | 0.42429971 |
| 78 | TIE1 | 0.41934820 |
| 79 | TTK | 0.39132529 |
| 80 | TEC | 0.39043887 |
| 81 | GSK3A | 0.38357259 |
| 82 | ERBB2 | 0.36570341 |
| 83 | CDK8 | 0.32632522 |
| 84 | MAP3K4 | 0.31780256 |
| 85 | CAMK1 | 0.31338910 |
| 86 | MAP2K6 | 0.29924211 |
| 87 | TRIM28 | 0.29556484 |
| 88 | RPS6KA6 | 0.27576429 |
| 89 | TGFBR1 | 0.26063235 |
| 90 | MAP3K5 | 0.25158624 |
| 91 | TNIK | 0.24612400 |
| 92 | PRKCG | 0.24567072 |
| 93 | BRSK2 | 0.23857274 |
| 94 | PRKG1 | 0.23612316 |
| 95 | PIM1 | 0.23579779 |
| 96 | CHEK2 | 0.23172984 |
| 97 | PRKG2 | 0.23147647 |
| 98 | NEK2 | 0.21919439 |
| 99 | PRKCI | 0.21866753 |
| 100 | TRPM7 | 0.21392426 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Regulation of autophagy_Homo sapiens_hsa04140 | 3.69600452 |
| 2 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.29840456 |
| 3 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 3.12389962 |
| 4 | One carbon pool by folate_Homo sapiens_hsa00670 | 3.09128569 |
| 5 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.90041234 |
| 6 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.81407504 |
| 7 | Proteasome_Homo sapiens_hsa03050 | 2.71249440 |
| 8 | Ribosome_Homo sapiens_hsa03010 | 2.32028256 |
| 9 | Mismatch repair_Homo sapiens_hsa03430 | 2.29593110 |
| 10 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.07990478 |
| 11 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 2.06687737 |
| 12 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.05564712 |
| 13 | RNA polymerase_Homo sapiens_hsa03020 | 1.96529471 |
| 14 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.94648289 |
| 15 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.88126782 |
| 16 | Phototransduction_Homo sapiens_hsa04744 | 1.86187755 |
| 17 | Basal transcription factors_Homo sapiens_hsa03022 | 1.83198549 |
| 18 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.79164439 |
| 19 | RNA degradation_Homo sapiens_hsa03018 | 1.73147473 |
| 20 | Homologous recombination_Homo sapiens_hsa03440 | 1.71817076 |
| 21 | Protein export_Homo sapiens_hsa03060 | 1.69715095 |
| 22 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.68871679 |
| 23 | Parkinsons disease_Homo sapiens_hsa05012 | 1.66654864 |
| 24 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.52064039 |
| 25 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.43825051 |
| 26 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.36812394 |
| 27 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.36274485 |
| 28 | Asthma_Homo sapiens_hsa05310 | 1.33722996 |
| 29 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.32541352 |
| 30 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.17855548 |
| 31 | Huntingtons disease_Homo sapiens_hsa05016 | 1.17046483 |
| 32 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.16836593 |
| 33 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.16592935 |
| 34 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.15754095 |
| 35 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.11232581 |
| 36 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.08701486 |
| 37 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.07385315 |
| 38 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.06520017 |
| 39 | Allograft rejection_Homo sapiens_hsa05330 | 1.00022502 |
| 40 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.99792048 |
| 41 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.96863078 |
| 42 | Alzheimers disease_Homo sapiens_hsa05010 | 0.93776258 |
| 43 | Purine metabolism_Homo sapiens_hsa00230 | 0.93577565 |
| 44 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.93365703 |
| 45 | Spliceosome_Homo sapiens_hsa03040 | 0.92425021 |
| 46 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.86781740 |
| 47 | RNA transport_Homo sapiens_hsa03013 | 0.86047857 |
| 48 | Sulfur relay system_Homo sapiens_hsa04122 | 0.85451997 |
| 49 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.85422011 |
| 50 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.83974600 |
| 51 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.83849309 |
| 52 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.83110011 |
| 53 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.82959620 |
| 54 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.81825889 |
| 55 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.80545302 |
| 56 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.80348091 |
| 57 | Retinol metabolism_Homo sapiens_hsa00830 | 0.79216741 |
| 58 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.79178682 |
| 59 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.77999275 |
| 60 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.74631624 |
| 61 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.73753291 |
| 62 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.73307058 |
| 63 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.71617155 |
| 64 | DNA replication_Homo sapiens_hsa03030 | 0.71280188 |
| 65 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.69340736 |
| 66 | Base excision repair_Homo sapiens_hsa03410 | 0.65162616 |
| 67 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.65066182 |
| 68 | Morphine addiction_Homo sapiens_hsa05032 | 0.64892490 |
| 69 | Metabolic pathways_Homo sapiens_hsa01100 | 0.62661330 |
| 70 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.60125581 |
| 71 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.59219309 |
| 72 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.58788826 |
| 73 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.58737762 |
| 74 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.58096704 |
| 75 | Lysine degradation_Homo sapiens_hsa00310 | 0.56478010 |
| 76 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.56244496 |
| 77 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.52941611 |
| 78 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.51978325 |
| 79 | Taste transduction_Homo sapiens_hsa04742 | 0.50998029 |
| 80 | Cell cycle_Homo sapiens_hsa04110 | 0.48872937 |
| 81 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.48288360 |
| 82 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.47914383 |
| 83 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.45517106 |
| 84 | Olfactory transduction_Homo sapiens_hsa04740 | 0.43519414 |
| 85 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.42773592 |
| 86 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.42078591 |
| 87 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.39764209 |
| 88 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.39561991 |
| 89 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.39313957 |
| 90 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.38187024 |
| 91 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.36981674 |
| 92 | Nicotine addiction_Homo sapiens_hsa05033 | 0.35420617 |
| 93 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.34977315 |
| 94 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.33843231 |
| 95 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.32159035 |
| 96 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.31620993 |
| 97 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.29612084 |
| 98 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.29367009 |
| 99 | Mineral absorption_Homo sapiens_hsa04978 | 0.28961737 |
| 100 | Peroxisome_Homo sapiens_hsa04146 | 0.28794782 |

